The FinElib consortium and Elsevier have signed a new 3-year Read and Publish agreement (2022–2024) to allow access to Cell Press journals and to enable researchers to publish open access without extra costs.→ Read more
Open Access publishing free of charge for researchers is increasing rapidly. Due to FinELib agreements, 65% more Open Access articles were published during the year 2020 than the year before.→ Read more
What are FinELib’s transformative agreements? What are their benefits to researchers? How do you determine a journal’s Plan S compliance?→ Read more
The report summarises the key conclusions of the project while also highlighting some of the actions institutions and stakeholders are urged to take to further promote the monitoring of APCs.→ Read more
Take advantage of open access benefits
During negotiations, open access benefits have been agreed upon regarding the journals of the following publishers:
More information about publisher- and organisation-specific open access benefits is also available from your own library.